ARDX
Ardelyx, Inc.
NASDAQ · USHealthcareBiotechnology
$5.09-2.12%
Price as of Jul 20, 2026
ARDX valuation
Ardelyx, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 35.02x
- P/E 2026E
- 315.19x
- P/E 2027E
- 9.78x
- P/E 2028E
- 4.34x
- P/S forward
- 2.01x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.46x
- Price / sales
- 2.94x
- Price / cash flow
- -34.67x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 2.87x
- EV / EBITDA
- -48.11x
- EV / EBIT
- -32.80x
- Market cap
- $1.3B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.